Results 21 to 30 of about 257,231 (311)

ROCK ‘n TOR: An Outlook on Keratinocyte Stem Cell Expansion in Regenerative Medicine via Protein Kinase Inhibition

open access: yesCells, 2022
Keratinocyte stem cells play a fundamental role in homeostasis and repair of stratified epithelial tissues. Transplantation of cultured keratinocytes autografts provides a landmark example of successful cellular therapies by restoring durable integrity ...
Giorgia Centonze   +3 more
doaj   +1 more source

Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance [PDF]

open access: yes, 2019
Sézary syndrome (SS) is a rare and aggressive variant of Cutaneous T-Cell Lymphoma characterized by neoplastic distribution mainly involving blood, skin, and lymph-node.
Benucci, Roberto   +15 more
core   +1 more source

Rapamycin maintains the primordial follicle pool and protects ovarian reserve against cyclophosphamide-induced damage

open access: yesThe Journal of Reproduction and Development, 2022
Any abnormal activation of primordial follicles and subsequent depletion can irreversibly diminish the ovarian reserve, which is one of the major chemotherapy-induced adverse effects in young patients with cancer.
Xiuying CHEN   +7 more
doaj   +1 more source

Autophagy processes are dependent on EGF receptor signaling [PDF]

open access: yes, 2018
Autophagy is a not well-understood conserved mechanism activated during nutritional deprivation in order to maintain cellular homeostasis. In the present study, we investigated the correlations between autophagy, apoptosis and the MAPK pathways in ...
Capodifoglio, Sabrina   +12 more
core   +1 more source

Prdx5 in the Regulation of Tuberous Sclerosis Complex Mutation-Induced Signaling Mechanisms

open access: yesCells, 2023
(1) Background: Tuberous sclerosis complex (TSC) mutations directly affect mTORC activity and, as a result, protein synthesis. In several cancer types, TSC mutation is part of the driver mutation panel.
Judit Bovari-Biri   +3 more
doaj   +1 more source

MTOR cross-talk in cancer and potential for combination therapy [PDF]

open access: yes, 2018
The mammalian Target of Rapamycin (mTOR) pathway plays an essential role in sensing and integrating a variety of exogenous cues to regulate cellular growth and metabolism, in both physiological and pathological conditions.
Bazzichetto, C.   +7 more
core   +3 more sources

Search for Synergistic Drug Combinations to Treat Chronic Lymphocytic Leukemia

open access: yesCells, 2022
Finding synergistic drug combinations is an important area of cancer research. Here, we sought to rationally design synergistic drug combinations with an inhibitor of BTK kinase, ibrutinib, which is used for the treatment of several types of leukemia. We
Eleonora Ela Hezkiy   +10 more
doaj   +1 more source

Rapamycin attenuates acute seizure-induced astrocyte injury in mice in vivo [PDF]

open access: yes, 2017
Astrocytes have been implicated in epileptogenesis and seizure-induced brain injury. Pathological studies reveal a variety of structural abnormalities in astrocytes, such as vacuolization and astrogliosis.
Guo, Dongjun, Wong, Michael, Zou, Jia
core   +2 more sources

mTORC1-Mediated Angiogenesis is Required for the Development of Rosacea

open access: yesFrontiers in Cell and Developmental Biology, 2021
Although multiple evidences suggest that angiogenesis is associated with the pathophysiology of rosacea, its role is still in debate. Here, we showed that angiogenesis was enhanced in skin lesions of both rosacea patients and LL37-induced rosacea-like ...
Qinqin Peng   +33 more
doaj   +1 more source

Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice [PDF]

open access: yes, 2016
The FDA approved drug rapamycin increases lifespan in rodents and delays age-related dysfunction in rodents and humans. Nevertheless, important questions remain regarding the optimal dose, duration, and mechanisms of action in the context of healthy ...
Anderson   +33 more
core   +1 more source

Home - About - Disclaimer - Privacy